The radiosensitizing effects of a STAT3/HDAC dual-target inhibitor derived from isoalantolactone in solid tumor models
Abstract Multi-target combination therapy has emerged as a promising anti-cancer strategy. STAT3 and HDAC are key contributors to tumorigenesis and progression. We previously reported the design of a novel dual-target inhibitor of STAT3 and HDAC (named mhl-28), which was developed by employing a nat...
Na minha lista:
| Principais autores: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-03-01
|
| Serier: | BMC Cancer |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s12885-026-15816-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
